IMPURITIES AVAILABLE FOR 'Bortezomib'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Bortezomib. Bortezomib is a proteasome inhibitor used primarily in the treatment of multiple myeloma and mantle cell lymphoma. It works by inhibiting the 26S proteasome, a cellular complex responsible for degrading unwanted or misfolded proteins. By blocking this process, bortezomib disrupts the regulated degradation of pro-apoptotic factors, leading to cancer cell death and reduced tumor growth. It also interferes with pathways involved in cell cycle control and angiogenesis. Bortezomib is administered via intravenous or subcutaneous injection, typically in cycles. Common side effects include fatigue, gastrointestinal upset, thrombocytopenia, peripheral neuropathy, and increased risk of infections. Dose adjustments are often necessary in patients with liver or kidney impairment. Due to its immunosuppressive effects, antiviral prophylaxis is recommended to prevent herpes zoster reactivation. Regular monitoring of blood counts and neurological status is essential during treatment. Buy high quality Bortezomib from Omsynth Lifesciences.